Related Experiment Video
Updated: Jul 3, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
A structural insight into CK2 inhibition
Marco Mazzorana1, Lorenzo A Pinna, Roberto Battistutta
1Department of Biological Chemistry, University of Padua, Padua, Italy.
Abstract:
The acidophilic Ser/Thr protein kinase CK2 displays some unique properties such as high pleiotropicity and constitutive activity. CK2 is involved in many fundamental aspects of the normal cell life, for instance it promotes cell survival and enhances the tumour phenotype under special circumstances. This makes CK2 an appealing target for the development of inhibitors with pharmacological potential. Here we present an overview of our recent studies on inhibitors directed to the CK2 ATP-binding site whose distinctive features are highlighted by the ability to use both ATP and GTP as co-substrates and by its low susceptibility to staurosporine inhibition. We discuss the effects of the binding of different chemical families of fairly selective inhibitors with potency in the nanomolar or low micromolar range. An important common energetic contribution to the binding is due to the hydrophobic interaction with the apolar surface region of the CK2 binding cleft. The analysis of the known CK2 crystal structures reveals the presence of some highly conserved water molecules in this region. These waters reside near Lys68, in an area with a positive electrostatic potential that is able to attract and orient negatively charged ligands. The presence of this positive region and of two unique bulky residues, Ile66 and Ile174, responsible for the reduced dimension of the CK2 active site, play a critical role in determining ligand orientation and binding selectivity.
Insights
Protein kinase CK2, a target for cancer therapy, has unique features making it drug-resistant. New inhibitors targeting its ATP-binding site show promise by exploiting hydrophobic interactions and conserved water molecules for selective binding.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The Ser/Thr protein kinase CK2 is a pleiotropic enzyme with constitutive activity.
- CK2 plays crucial roles in normal cellular processes, including cell survival.
- CK2 also contributes to tumor progression, making it a significant therapeutic target.
Purpose of the Study:
- To review recent studies on inhibitors targeting the CK2 ATP-binding site.
- To highlight the unique features of CK2, such as its ability to use both ATP and GTP and resistance to staurosporine.
- To discuss the binding characteristics and selectivity of various chemical inhibitor families.
Main Methods:
- Analysis of CK2 crystal structures.
- Investigation of inhibitor binding to the CK2 ATP-binding site.
- Evaluation of inhibitor potency and selectivity.
Main Results:
- Selective inhibitors with nanomolar to low micromolar potency were identified.
- Hydrophobic interactions with the CK2 binding cleft are a key binding contributor.
- Conserved water molecules near Lys68 and bulky residues (Ile66, Ile174) influence ligand orientation and selectivity.
Conclusions:
- CK2 inhibitors can be developed by targeting the ATP-binding site.
- Understanding the structural features of the active site is critical for designing selective inhibitors.
- These findings provide a basis for developing novel CK2-targeted therapeutics.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11:27A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Enzyme Inhibition
Feedback Inhibition
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Positive Regulator Molecules